Stocks and Investing Stocks and Investing
Tue, June 27, 2023
Mon, June 26, 2023

Andrew Fein Reiterated (VRTX) at Strong Buy and Held Target at $380 on, Jun 26th, 2023


Published on 2024-10-28 04:31:12 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Reiterated "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy and Held Target at $380 on, Jun 26th, 2023.

Andrew has made no other calls on VRTX in the last 4 months.



There are 18 other peers that have a rating on VRTX. Out of the 18 peers that are also analyzing VRTX, 4 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Brian Abrahams of "RBC Capital" Reiterated at Hold and Held Target at $323 on, Thursday, June 22nd, 2023
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $305 on, Tuesday, May 2nd, 2023
  • Paul Matteis of "Stifel" Maintained at Hold with Increased Target to $340 on, Tuesday, May 2nd, 2023
  • Brian Skorney of "Baird" Maintained at Hold with Increased Target to $325 on, Tuesday, May 2nd, 2023


These are the ratings of the 14 analyists that currently disagree with Andrew


  • Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $365 on, Friday, June 23rd, 2023
  • Myles Minter of "William Blair" Initiated at Buy on, Tuesday, May 30th, 2023
  • Christopher Raymond of "Piper Sandler" Initiated at Buy and Held Target at $385 on, Thursday, May 4th, 2023
  • Jason McCarthy of "Maxim Group" Maintained at Strong Buy with Increased Target to $400 on, Wednesday, May 3rd, 2023
  • William Pickering of "Bernstein" Maintained at Buy with Increased Target to $363 on, Wednesday, May 3rd, 2023
  • Jessica Fye of "JP Morgan" Maintained at Buy and Held Target at $345 on, Tuesday, May 2nd, 2023
  • Phil Nadeau of "TD Cowen" Maintained at Buy with Increased Target to $350 on, Tuesday, May 2nd, 2023
  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $456 on, Tuesday, May 2nd, 2023
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $399 on, Tuesday, May 2nd, 2023
  • Debjit Chattopadhyay of "Guggenheim" Maintained at Strong Buy with Increased Target to $385 on, Tuesday, May 2nd, 2023
  • Evan Seigerman of "BMO Capital" Maintained at Buy and Held Target at $385 on, Tuesday, May 2nd, 2023
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $384 on, Tuesday, May 2nd, 2023
  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $410 on, Tuesday, May 2nd, 2023
  • Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Increased Target to $350 on, Wednesday, March 29th, 2023

Contributing Sources